[
  {
    "ts": null,
    "headline": "Lilly to give biotech startups access to AI tools",
    "summary": "Insitro, Firefly Bio and Superluminal Medicines are among the first participants in Lilly’s “TuneLabs” platform, which the pharma says can help young drugmakers while training its own models.",
    "url": "https://finnhub.io/api/news?id=4f62422493af24d1aec3be477ebf8d0ff4c55e34ad4a1f91789da6593a16ec80",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1757440740,
      "headline": "Lilly to give biotech startups access to AI tools",
      "id": 136688594,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "LLY",
      "source": "Yahoo",
      "summary": "Insitro, Firefly Bio and Superluminal Medicines are among the first participants in Lilly’s “TuneLabs” platform, which the pharma says can help young drugmakers while training its own models.",
      "url": "https://finnhub.io/api/news?id=4f62422493af24d1aec3be477ebf8d0ff4c55e34ad4a1f91789da6593a16ec80"
    }
  },
  {
    "ts": null,
    "headline": "Metsera: An Emerging Contender In The GLP‑1 Arena",
    "summary": "Discover Metsera's potential in the obesity drug market. Learn why I rate it a HOLD amid upcoming trial results.",
    "url": "https://finnhub.io/api/news?id=6ef362478f8ffcc2e5175cbb3c2475dcb875cc039a69581a2a4536975b4fd9c8",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1757438822,
      "headline": "Metsera: An Emerging Contender In The GLP‑1 Arena",
      "id": 136679856,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2184958576/image_2184958576.jpg?io=getty-c-w1536",
      "related": "LLY",
      "source": "SeekingAlpha",
      "summary": "Discover Metsera's potential in the obesity drug market. Learn why I rate it a HOLD amid upcoming trial results.",
      "url": "https://finnhub.io/api/news?id=6ef362478f8ffcc2e5175cbb3c2475dcb875cc039a69581a2a4536975b4fd9c8"
    }
  },
  {
    "ts": null,
    "headline": "Eli Lilly & Co. stock outperforms competitors on strong trading day",
    "summary": "Eli Lilly & Co. stock outperforms competitors on strong trading day",
    "url": "https://finnhub.io/api/news?id=ceb729f41cca94dd339e8cd8c28c6be96fecf3ba59b4ad67653fa13cb2469f33",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1757435460,
      "headline": "Eli Lilly & Co. stock outperforms competitors on strong trading day",
      "id": 136712937,
      "image": "",
      "related": "LLY",
      "source": "MarketWatch",
      "summary": "Eli Lilly & Co. stock outperforms competitors on strong trading day",
      "url": "https://finnhub.io/api/news?id=ceb729f41cca94dd339e8cd8c28c6be96fecf3ba59b4ad67653fa13cb2469f33"
    }
  },
  {
    "ts": null,
    "headline": "Wall Street Lunch: US Labor Market Sees Big Downward Revisions",
    "summary": "The U.S. added 911,000 fewer jobs in the 12 months through March 2025, the Bureau of Labor Statisticsâ preliminary benchmark revision showed.",
    "url": "https://finnhub.io/api/news?id=ff65d69942f53746134e0ffb7ae63020fb38903a93a19562b13be67d3c035ddd",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1757425362,
      "headline": "Wall Street Lunch: US Labor Market Sees Big Downward Revisions",
      "id": 136678310,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1044909162/image_1044909162.jpg?io=getty-c-w1536",
      "related": "LLY",
      "source": "SeekingAlpha",
      "summary": "The U.S. added 911,000 fewer jobs in the 12 months through March 2025, the Bureau of Labor Statisticsâ preliminary benchmark revision showed.",
      "url": "https://finnhub.io/api/news?id=ff65d69942f53746134e0ffb7ae63020fb38903a93a19562b13be67d3c035ddd"
    }
  },
  {
    "ts": null,
    "headline": "1 Reason Every Investor Should Know About Novo Nordisk (NVO)",
    "summary": "The company could be on the verge of turning the tide in the battle over weight loss drugs.",
    "url": "https://finnhub.io/api/news?id=8d12542add7028450ccef2e307cd462ea2fcad3289913ecf7372acf68fd6784d",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1757383200,
      "headline": "1 Reason Every Investor Should Know About Novo Nordisk (NVO)",
      "id": 136674197,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "LLY",
      "source": "Yahoo",
      "summary": "The company could be on the verge of turning the tide in the battle over weight loss drugs.",
      "url": "https://finnhub.io/api/news?id=8d12542add7028450ccef2e307cd462ea2fcad3289913ecf7372acf68fd6784d"
    }
  },
  {
    "ts": null,
    "headline": "Eli Lilly (LLY) Laps the Stock Market: Here's Why",
    "summary": "Eli Lilly (LLY) concluded the recent trading session at $738.17, signifying a +1.51% move from its prior day's close.",
    "url": "https://finnhub.io/api/news?id=1b55056f2e19257794e1515a124d645cd887412f47de3e62fadf31388851a612",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1757377991,
      "headline": "Eli Lilly (LLY) Laps the Stock Market: Here's Why",
      "id": 136674198,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "LLY",
      "source": "Yahoo",
      "summary": "Eli Lilly (LLY) concluded the recent trading session at $738.17, signifying a +1.51% move from its prior day's close.",
      "url": "https://finnhub.io/api/news?id=1b55056f2e19257794e1515a124d645cd887412f47de3e62fadf31388851a612"
    }
  }
]